Human imprinting anomalies in fetal and childhood growth disorders: Clinical implications and molecular mechanisms

Current Pharmaceutical Design

Volumn 20, Issue 11, 2014, Pages 1751-1763

  Azzi, Salah ^a,b   Brioude, Fréderic ^a,b   Le Bouc, Yves ^a,b   Netchine, Irène ^a,b  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

Author keywords

AS; BWS; Chromosome 14 related syndromes; Epigenetic regulation; Genomic impirinting; Growth disorders; Human impriting syndrome; PHP 1b; PWS; RSS; TNDM

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C; DNA METHYLTRANSFERASE 3A; GROWTH FACTOR RECEPTOR BOUND PROTEIN 10; MICRORNA; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNTRANSLATED RNA;

ALLELE; ARTICLE; BECKWITH WIEDEMANN SYNDROME; CELL CYCLE REGULATION; CHILDHOOD DISEASE; CHROMOSOME 14; CLINICAL FEATURE; COPY NUMBER VARIATION; CPG ISLAND; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; FETUS DEVELOPMENT; FOLLOW UP; GENE EXPRESSION; GENE LOCUS; GENOME IMPRINTING; GENOTYPE PHENOTYPE CORRELATION; GROWTH DISORDER; HEREDITY; HUMAN; INFERTILITY THERAPY; MOLECULAR PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PSEUDOHYPOPARATHYROIDISM; SILVER RUSSELL SYNDROME; UNIPARENTAL DISOMY; ANIMAL; FETAL GROWTH RETARDATION; GENETIC EPIGENESIS; GENETICS; GROWTH DISORDERS; MUTATION; PRACTICE GUIDELINE; SYNDROME;

ALLELES; ANIMALS; DNA COPY NUMBER VARIATIONS; EPIGENESIS, GENETIC; FETAL GROWTH RETARDATION; GENOMIC IMPRINTING; GROWTH DISORDERS; HUMANS; MUTATION; PRACTICE GUIDELINES AS TOPIC; REPRODUCTIVE TECHNIQUES, ASSISTED; SYNDROME;

EID: 84903723489     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990525     Document Type: Article

References (144)

1. Gicquel C, El-Osta A, Le Bouc Y. Epigenetic regulation and fetal programming, Best Pract Res Clin Endocrinol Metab 202008; 22: 1-16.
2. Barker DJ. Maternal and fetal origins of coronary heart disease, J R Coll Physicians Lond 1994; 28: 544-51.
3. Smith RJ, Dean W, Konfortova G, Kelsey G. Identification of novel imprinted genes in a genome-wide screen for maternal methylation, Genome Res 202003; 13: 558-69.
4. Edwards CA, Ferguson-Smith AC. Mechanisms regulating imprinted genes in clusters, Curr Opin Cell Biol 202007; 19: 281-9.
5. Guibert S, Forne T, Weber M. Global profiling of DNA methylation erasure in mouse primordial germ cells, Genome Res 202012; 22: 633-41.
6. Ginsburg M, Snow MH, McLaren A. Primordial germ cells in the mouse embryo during gastrulation, Development 1990; 110: 521-8.
7. Hajkova P, Erhardt S, Lane N, et al. Epigenetic reprogramming in mouse primordial germ cells, Mech Dev 202002;2002; 117: 15-23.
8. Szabo PE, Hubner K, Scholer H, Mann JR. Allele-specific expression of imprinted genes in mouse migratory primordial germ cells, Mech Dev 2002; 115: 157-60.
9. Lee J, Inoue K, Ono R, et al. Erasing genomic imprinting memory in mouse clone embryos produced from day 11.5 primordial germ cells, Development 2002; 129: 1807-17.
10. Seisenberger S, Andrews S, Krueger F, et al. The Dynamics of Genome-wide DNA Methylation Reprogramming in Mouse Primordial Germ Cells, Mol Cell 202012; 48: 849-62.
11. Seisenberger S, Peat JR, Hore TA, et al. Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers, Philos Trans R Soc Lond B Biol Sci 2013; 368: 20110330.
12. Kato Y, Kaneda M, Hata K, et al. Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse, Hum Mol Genet 202007; 16: 2272-80.
13. Morgan HD, Santos F, Green K, Dean W, Reik W. Epigenetic reprogramming in mammals, Hum Mol Genet 2005; 14 Spec No 1: R47-58.
14. Smallwood SA, Tomizawa S, Krueger F, et al. Dynamic CpG island methylation landscape in oocytes and preimplantation embryos, Nat Genet 202011; 43: 811-4.
15. Fedoriw AM, Stein P, Svoboda P, Schultz RM, Bartolomei MS. Transgenic RNAi reveals essential function for CTCF in H19 gene imprinting, Science 202004; 303: 238-40.
16. Li X, Ito M, Zhou F, et al. A maternal-zygotic effect gene, Zfp57, maintains both maternal and paternal imprints, Dev Cell 2008; 15: 547-57.
17. Jelinic P, Stehle JC, Shaw P. The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation, PLoS Biol 2006; 4: e355.
18. Santos F, Hendrich B, Reik W, Dean W. Dynamic reprogramming of DNA methylation in the early mouse embryo, Dev Biol 2002; 241: 172-82.
19. Wossidlo M, Arand J, Sebastiano V, et al. Dynamic link of DNA demethylation, DNA strand breaks and repair in mouse zygotes, Embo J 202010; 29: 1877-88.
20. Hajkova P, Jeffries SJ, Lee C, et al. Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway, Science 202010; 329: 78-82.
21. Okada Y, Yamagata K, Hong K, Wakayama T, Zhang Y. A role for the elongator complex in zygotic paternal genome demethylation, Nature 202010; 463: 554-8.
22. Wossidlo M, Nakamura T, Lepikhov K, et al. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming, Nat Commun 2011; 2: 241.
23. Howell CY, Bestor TH, Ding F, et al. Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene, Cell 20 2001; 104: 829-38.
24. Nakamura T, Arai Y, Umehara H, et al. PGC7/Stella protects against DNA demethylation in early embryogenesis, Nat Cell Biol 202007; 9: 64-71.
25. Gowher H, Stuhlmann H, Felsenfeld G. Vezf1 regulates genomic DNA methylation through its effects on expression of DNA methyltransferase Dnmt3b, Genes Dev 202008; 22: 2075-84.
26. Mackay DJ, Callaway JL, Marks SM, et al. Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57, Nat Genet 202008; 40: 949-51.
27. Robertson KD. DNA methylation and human disease, Nat Rev Genet 2005; 6: 597-610.
28. Reik W, Walter J. Genomic imprinting: parental influence on the genome, Nat Rev Genet 2001; 2: 21-32.
29. Constancia M, Dean W, Lopes S, et al. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19, Nat Genet 20 2000; 26: 203-6.
30. Feil R, Walter J, Allen ND, Reik W. Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes, Development 1994; 120: 2933-43.
31. Takada S, Paulsen M, Tevendale M, et al. Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome 12: implications for imprinting control from comparison with Igf2-H19, Hum Mol Genet 2002; 11: 77-86.
32. Nicholls RD. The impact of genomic imprinting for neurobehavioral and developmental disorders, J Clin Invest 2000; 105: 413-8.
33. Tycko B, Morison IM. Physiological functions of imprinted genes, J Cell Physiol 2002; 192: 245-58.
34. Silver HK, Kiyasu W, George J, Deamer WC. Syndrome of congenital hemihypertrophy, shortness of stature, and elevated urinary gonadotropins, Pediatrics 1953; 12: 368-76.
35. Russell A. A syndrome of intra-uterine dwarfism recognizable at birth with cranio-facial dysostosis, disproportionately short arms, and other anomalies (5 examples), Proc R Soc Med 1954; 47: 1040-4.
36. Netchine I, Rossignol S, Dufourg MN, et al. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations, J Clin Endocrinol Metab 202007; 92: 3148-54.
37. Price SM, Stanhope R, Garrett C, Preece MA, Trembath RC. The spectrum of Silver-Russell syndrome: a clinical and molecular genetic study and new diagnostic criteria, J Med Genet 1999; 36: 837-42.
38. Abu-Amero S, Wakeling EL, Preece M, et al. Epigenetic signatures of Silver-Russell syndrome, J Med Genet 2010; 47: 150-4.
39. Wakeling EL, Amero SA, Alders M, et al. Epigenotype-phenotype correlations in Silver-Russell syndrome, J Med Genet 2010; 47: 760-8.
40. Usher R, McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation, J Pediatr 1969; 74: 901-10.
41. Hitchins MP, Stanier P, Preece MA, Moore GE. Silver-Russell syndrome: a dissection of the genetic aetiology and candidate chromosomal regions, J Med Genet 2001; 38: 810-9.
42. Preece MA. The genetics of the Silver-Russell syndrome, Rev Endocr Metab Disord 2002; 3: 369-79.
43. Joyce CA, Sharp A, Walker JM, Bullman H, Temple IK. Duplication of 7p12.1-p13, including GRB10 and IGFBP1, in a mother and daughter with features of Silver-Russell syndrome, Hum Genet 1999; 105: 273-80.
44. Monk D, Wakeling EL, Proud V, et al. Duplication of 7p11.2-p13, including GRB10, in Silver-Russell syndrome, Am J Hum Genet 2000; 66: 36-46.
45. Hannula K, Lipsanen-Nyman M, Kontiokari T, Kere J. A narrow segment of maternal uniparental disomy of chromosome 7q31-qter in Silver-Russell syndrome delimits a candidate gene region, Am J Hum Genet 2001; 68: 247-53.
46. Yoshihashi H, Maeyama K, Kosaki R, et al. Imprinting of human GRB10 and its mutations in two patients with Russell-Silver syndrome, Am J Hum Genet 2000; 67: 476-82.
47. Hitchins MP, Monk D, Bell GM, et al. Maternal repression of the human GRB10 gene in the developing central nervous system; evaluation of the role for GRB10 in Silver-Russell syndrome, Eur J Hum Genet 2001; 9: 82-90.
48. McCann JA, Zheng H, Islam A, Goodyer CG, Polychronakos C. Evidence against GRB10 as the gene responsible for Silver-Russell syndrome, Biochem Biophys Res Commun 2001; 286: 943-8.
49. Arnaud P, Monk D, Hitchins M, et al. Conserved methylation imprints in the human and mouse GRB10 genes with divergent allelic expression suggests differential reading of the same mark, Hum Mol Genet 2003; 12: 1005-19.
50. Kobayashi S, Uemura H, Kohda T, et al. No evidence of PEG1/MEST gene mutations in Silver-Russell syndrome patients, Am J Med Genet 2001; 104: 225-31.
51. Riesewijk AM, Blagitko N, Schinzel AA, et al. Evidence against a major role of PEG1/MEST in Silver-Russell syndrome, Eur J Hum Genet 1998; 6: 114-20.
52. Kagami M, Nagai T, Fukami M, Yamazawa K, Ogata T. Silver-Russell syndrome in a girl born after in vitro fertilization: partial hypermethylation at the differentially methylated region of PEG1/MEST, J Assist Reprod Genet 2007; 24: 131-6.
53. Eggermann T, Spengler S, Begemann M, et al. Deletion of the paternal allele of the imprinted MEST/PEG1 region in a patient with Silver-Russell syndrome features, Clin Genet 2012; 81: 298-300.
54. Eggermann T, Meyer E, Obermann C, et al. Is maternal duplication of 11p15 associated with Silver-Russell syndrome, J Med Genet 2005; 42: e26.
55. Fisher AM, Thomas NS, Cockwell A, et al. Duplications of chromosome 11p15 of maternal origin result in a phenotype that includes growth retardation, Hum Genet 2002; 111: 290-6.
56. Gicquel C, Rossignol S, Cabrol S, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome, Nat Genet 2005; 37: 1003-7.
57. Schonherr N, Meyer E, Roos A, et al. The centromeric 11p15 imprinting centre is also involved in Silver-Russell syndrome, J Med Genet 2007; 44: 59-63.
58. Bonaldi A, Mazzeu JF, Costa SS, et al. Microduplication of the ICR2 domain at chromosome 11p15 and familial Silver-Russell syndrome, Am J Med Genet A 155A: 2479-83.
59. Binder G, Begemann M, Eggermann T, Kannenberg K. Silver-Russell syndrome, Best Pract Res Clin Endocrinol Metab 2011; 25: 153-60.
60. Guettard E, Portnoi MF, Lohmann-Hedrich K, et al. Myoclonusdystonia due to maternal uniparental disomy, Arch Neurol 2008; 65: 1380-5.
61. International Molecular Genetic Study of Autism Consortium (IMGSAC). A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p, Am J Hum Genet 2001; 69: 570-81.
62. Bliek J, Terhal P, van den Bogaard MJ, et al. Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype, Am J Hum Genet 202006; 78, 604-14.
63. Murphy R, Ibanez L, Hattersley A, Tost J. IGF2/H19 hypomethylation in a patient with very low birthweight, preocious pubarche and insulin resistance, BMC Med Genet 202012; 13: 42.
64. Gicquel C RS., Le Bouc Y. Beckwith-Wiedemann syndrome, Orphanet Encyclopedia 2005.
65. Gaston V, Le Bouc Y, Soupre V, et al. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome, Eur J Hum Genet 2001; 9: 409-18.
66. Schneid H, Seurin D, Vazquez MP, et al. Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome, J Med Genet 1993: 30, 353-62.
67. Demars J, Gicquel C. Epigenetic and genetic disturbance of the imprinted 11p15 region in Beckwith-Wiedemann and Silver-Russell syndromes, Clin Genet 202012; 81: 350-61.
68. Nakadate H, Yokomori K, Watanabe N, et al. Mutations/deletions of the WT1 gene, loss of heterozygosity on chromosome arms 11p and 11q, chromosome ploidy and histology in Wilms' tumors in Japan, Int J Cancer 2001; 94: 396-400.
69. Yuan E, Li CM, Yamashiro DJ, et al. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors, Mol Cancer Res 2005; 3: 493-502.
70. Cooper WN, Luharia A, Evans GA, et al. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome, Eur J Hum Genet 2005; 13: 1025-32.
71. Rossignol S, Steunou V, Chalas C, et al. The epigenetic imprinting defect of patients with Beckwith-Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region, J Med Genet 2006; 43: 902-7.
72. Tan WH, Bacino CA, Skinner SA, et al. Angelman syndrome: Mutations influence features in early childhood, Am J Med Genet A 155A: 81-90.
73. Hayward BE, Kamiya M, Strain L, et al. The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins, Proc Natl Acad Sci U S A 1998; 95: 10038-43.
74. Bastepe M, Frohlich LF, Hendy GN, et al. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS, J Clin Invest 2003; 112: 1255-63.
75. Bastepe M, Frohlich LF, Linglart A, et al. Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib, Nat Genet 2005; 37: 25-7.
76. Chillambhi S, Turan S, Hwang DY, et al. Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis, J Clin Endocrinol Metab 2010; 95: 3993-4002.
77. Richard N, Abeguile G, Coudray N, et al. A New Deletion Ablating NESP55 Causes Loss of Maternal Imprint of A/B GNAS and Autosomal Dominant Pseudohypoparathyroidism Type Ib, J Clin Endocrinol Metab 2012; 97: E863-7.
78. Chotalia M, Smallwood SA, Ruf N, et al. Transcription is required for establishment of germline methylation marks at imprinted genes, Genes Dev 2009; 23: 105-17.
79. Mantovani G, Spada A. Mutations in the Gs alpha gene causing hormone resistance, Best Pract Res Clin Endocrinol Metab 2006; 20: 501-13.
80. Bastepe M. The GNAS locus and pseudohypoparathyroidism, Adv Exp Med Biol 2008; 626: 27-40.
81. de Nanclares GP, Fernandez-Rebollo E, Santin I, et al. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy, J Clin Endocrinol Metab 2007; 92: 2370-3.
82. Bastepe M, Juppner H. GNAS locus and pseudohypoparathyroidism, Horm Res 2005; 63: 65-74.
83. Linglart A, Bastepe M, Juppner H. Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus, Clin Endocrinol (Oxf) 202007; 67: 822-31.
84. Varrault A, Ciani E, Apiou F, et al. hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer, Proc Natl Acad Sci USA 1998; 95: 8835-40.
85. Valente T, Junyent F, Auladell C. Zac1 is expressed in progenitor/ stem cells of the neuroectoderm and mesoderm during embryogenesis: differential phenotype of the Zac1-expressing cells during development, Dev Dyn 2005; 233: 667-79.
86. Valente T, Auladell C. Expression pattern of Zac1 mouse gene, a new zinc-finger protein that regulates apoptosis and cellular cycle arrest, in both adult brain and along development, Mech Dev 2001; 108: 207-11.
87. Varrault A, Gueydan C, Delalbre A, et al. Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth, Dev Cell 202006; 11: 711-22.
88. Ma D, Shield JP, Dean W, et al. Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM, J Clin Invest 2004; 114: 339-48.
89. Arima T, Drewell RA, Arney KL, et al. A conserved imprinting control region at the HYMAI/ZAC domain is implicated in transient neonatal diabetes mellitus, Hum Mol Genet 2001; 10: 1475-83.
90. Diatloff-Zito C, Nicole A, Marcelin G, et al. Genetic and epigenetic defects at the 6q24 imprinted locus in a cohort of 13 patients with transient neonatal diabetes: new hypothesis raised by the finding of a unique case with hemizygotic deletion in the critical region, J Med Genet 2007; 44: 31-7.
91. Arima T, Drewell RA, Oshimura M, Wake N, Surani MA. A novel imprinted gene, HYMAI, is located within an imprinted domain on human chromosome 6 containing ZAC, Genomics 20 2000; 67: 248-55.
92. Temple IK, Shield JP. Transient neonatal diabetes, a disorder of imprinting, J Med Genet 2002; 39: 872-5.
93. Arthur EI, Zlotogora J, Lerer I, et al. Transient neonatal diabetes mellitus in a child with invdup(6)(q22q23) of paternal origin, Eur J Hum Genet 1997; 5: 417-9.
94. Temple IK, Gardner RJ, Robinson DO, et al. Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23, Hum Mol Genet 1996; 5: 1117-21.
95. Christian SL, Rich BH, Loebl C, et al. Significance of genetic testing for paternal uniparental disomy of chromosome 6 in neonatal diabetes mellitus, J Pediatr 1999; 134: 42-6.
96. Das S, Lese CM, Song M, et al. Partial paternal uniparental disomy of chromosome 6 in an infant with neonatal diabetes, macroglossia, and craniofacial abnormalities, Am J Hum Genet 2000; 67: 1586-91.
97. Flanagan SE, Patch AM, Mackay DJ, et al. Mutations in ATPsensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood, Diabetes 2007; 56: 1930-7.
98. Mackay DJ, Temple IK, Shield JP, Robinson DO. Bisulphite sequencing of the transient neonatal diabetes mellitus DMR facilitates a novel diagnostic test but reveals no methylation anomalies in patients of unknown aetiology, Hum Genet 2005; 116: 255-61.
99. Wan LB, Bartolomei MS. Regulation of imprinting in clusters: noncoding RNAs versus insulators, Adv Genet 2008; 61: 207-23.
100. da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson-Smith AC. Genomic imprinting at the mammalian Dlk1-Dio3 domain, Trends Genet 2008; 24: 306-16.
101. Sutton VR, Shaffer LG. Search for imprinted regions on chromosome 14: comparison of maternal and paternal UPD cases with cases of chromosome 14 deletion, Am J Med Genet 2000; 93: 381-7.
102. Hoffmann K, Heller R. Uniparental disomies 7 and 14, Best Pract Res Clin Endocrinol Metab, 25: 77-100.
103. Kagami M, Kato F, Matsubara K, et al. Relative frequency of underlying genetic causes for the development of UPD(14)pat-like phenotype, Eur J Hum Genet 2012.
104. Temple IK, Shrubb V, Lever M, Bullman H, Mackay DJ. Isolated imprinting mutation of the DLK1/GTL2 locus associated with a clinical presentation of maternal uniparental disomy of chromosome 14, J Med Genet 202007; 44: 637-40.
105. Kagami M, Sekita Y, Nishimura G, et al. Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes, Nat Genet 2008; 40: 237-42.
106. Buiting K, Kanber D, Martin-Subero JI, et al. Clinical features of maternal uniparental disomy 14 in patients with an epimutation and a deletion of the imprinted DLK1/GTL2 gene cluster, Hum Mutat 2008; 29: 1141-6.
107. Hosoki K, Ogata T, Kagami M, Tanaka T, Saitoh S. Epimutation (hypomethylation) affecting the chromosome 14q32.2 imprinted region in a girl with upd(14)mat-like phenotype, Eur J Hum Genet 2008; 16: 1019-23.
108. Zechner U, Kohlschmidt N, Rittner G, et al. Epimutation at human chromosome 14q32.2 in a boy with a upd(14)mat-like clinical phenotype, Clin Genet 2009; 75: 251-8.
109. Horsthemke B, Wagstaff J. Mechanisms of imprinting of the Prader-Willi/Angelman region, Am J Med Genet A 2008; 146A: 2041-52.
110. Buiting K, Barnicoat A, Lich C, et al. Disruption of the bipartite imprinting center in a family with Angelman syndrome, Am J Hum Genet 2001; 68: 1290-4.
111. Prader A., Labhart A., Willi H. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach Myatonieartigem Zustand im Neugeborenenalter, Schweiz. Med. Wschr 1956, 86, 1260-1261.
112. Van Buggenhout G, Fryns JP. Angelman syndrome (AS, MIM 105830), Eur J Hum Genet 2009; 17: 1367-73.
113. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome, Nat Genet 1997, 15, 70-3.
114. Maupetit-Mehouas S, Mariot V, Reynes C, et al. Quantification of the methylation at the GNAS locus identifies subtypes of sporadic pseudohypoparathyroidism type Ib, J Med Genet 2011; 48: 55-63.
115. Fraga MF, Esteller M. DNA methylation: a profile of methods and applications, Biotechniques 2002; 33: 632, 634, 636-49.
116. Azzi S, Rossignol S, Steunou V, et al. Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci, Hum Mol Genet 2009; 18: 4724-33.
117. Azzi S, Rossignol S, Le Bouc Y, Netchine I. Lessons from imprinted multilocus loss of methylation in human syndromes: A step toward understanding the mechanisms underlying these complex diseases, Epigenetics 2010; 5: 373-7.
118. Mackay DJ, Boonen SE, Clayton-Smith J, et al. A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus, Hum Genet 2006; 120: 262-9.
119. Bliek J, Verde G, Callaway J, et al. Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-Wiedemann syndrome, Eur J Hum Genet 2009; 17: 611-9.
120. Meyer E, Lim D, Pasha S, et al. Germline mutation in NLRP2 (NALP2) in a familial imprinting disorder (Beckwith-Wiedemann Syndrome), PLoS Genet 2009; 5: e1000423.
121. Hiura H, Okae H, Miyauchi N, et al. Characterization of DNA methylation errors in patients with imprinting disorders conceived by assisted reproduction technologies, Hum Reprod 2012.
122. Begemann M, Leisten I, Soellner L, et al. Use of multilocus methylation-specific single nucleotide primer extension (MS-SNuPE) technology in diagnostic testing for human imprinted loci, Epigenetics 2012; 7: 473-81.
123. Kannenberg K, Urban C, Binder G. Increased incidence of aberrant DNA methylation within diverse imprinted gene loci outside of IGF2/H19 in Silver-Russell syndrome, Clin Genet 202012; 81, 366-77.
124. Turner CL, Mackay DM, Callaway JL, et al. Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted loci, Eur J Hum Genet 2010; 18: 648-55.
125. Perez-Nanclares G, Romanelli V, Mayo S, et al. Detection of Hypomethylation Syndrome among Patients with Epigenetic Alterations at the GNAS Locus, J Clin Endocrinol Metab 2012; 97: E1060-E1067.
126. Chedin F, Lieber MR, Hsieh CL. The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a, Proc Natl Acad Sci U S A 2002; 99: 16916-21.
127. Hata K, Okano M, Lei H, Li E. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice, Development 2002; 129: 1983-93.
128. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality, Cell 1992, 69: 915-26.
129. Demars J, Shmela ME, Rossignol S, et al. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders, Hum Mol Genet 2010; 19: 803-14.
130. Demars J, Rossignol S, Netchine I, et al. New insights into the pathogenesis of Beckwith-Wiedemann and Silver-Russell syndromes: contribution of small copy number variations to 11p15 imprinting defects, Hum Mutat 202011; 32, 1171-82.
131. Poole RL, Leith DJ, Docherty LE, et al. Beckwith-Wiedemann syndrome caused by maternally inherited mutation of an OCTbinding motif in the IGF2/H19-imprinting control region, ICR1, Eur J Hum Genet 2011; 20: 240-3.
132. Weth O, Renkawitz R. CTCF function is modulated by neighboring DNA binding factors, Biochem Cell Biol 2011; 89: 459-68.
133. Waterland RA, Lin JR, Smith CA, Jirtle RL. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus, Hum Mol Genet 2006; 15: 705-16.
134. Heijmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans, Proc Natl Acad Sci U S A 2008; 105: 17046-9.
135. Ingrosso D, Cimmino A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia, Lancet 2003; 361: 1693-9.
136. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins, Proc Natl Acad Sci U S A 2005; 102: 10604-9.
137. Haque FN, Gottesman II; Wong AH. Not really identical: epigenetic differences in monozygotic twins and implications for twin studies in psychiatry, Am J Med Genet C Semin Med Genet 2009; 151C: 136-41.
138. Kaminsky ZA, Tang T, Wang SC, et al. DNA methylation profiles in monozygotic and dizygotic twins, Nat Genet 2009; 41: 240-5.
139. Choi JK, Kim SC. Environmental effects on gene expression phenotype have regional biases in the human genome, Genetics 2007; 175: 1607-13.
140. Sharma A, Sharma VK, Horn-Saban S, et al. Assessing natural variations in gene expression in humans by comparing with monozygotic twins using microarrays, Physiol Genomics 2005; 21: 117-23.
141. Gicquel C, Gaston V, Mandelbaum J, et al. In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene, Am J Hum Genet 2003; 72: 1338-41.
142. Amor DJ, Halliday J. A review of known imprinting syndromes and their association with assisted reproduction technologies, Hum Reprod 2008; 23: 2826-34.
143. Eroglu A, Layman LC. Role of ART in imprinting disorders, Semin Reprod Med 2012; 30: 92-104.
144. Kobayashi H, Hiura, H, John RM, et al. DNA methylation errors at imprinted loci after assisted conception originate in the parental sperm, Eur J Hum Genet 2009; 17: 1582-91.